M&A Deal Summary |
|
|---|---|
| Date | 2024-10-24 |
| Target | BioEcho Life Sciences |
| Sector | Life Science |
| Buyer(s) | Admera Health |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
| Advisor(s) | EC M&A (Financial) |
SEARCH BY
Admera Health is a genomics and bioinformatics services company that supports research programs in academia, biotechnology, and pharmaceutical development. Its CLIA?certified, CAP?accredited laboratory offers next?generation sequencing (NGS) services including whole genome sequencing, transcriptomics, epigenomics, and custom panels, backed by in?house scientific support. Admera Health is based in South Plainfield, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 56 of 56 |
| Sector: Life Science M&A | 26 of 26 |
| Type: Add-on Acquisition M&A Deals | 39 of 39 |
| Country: Germany M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-19 |
Biologos
Montgomery, Illinois, United States Biologos is a provider of sterile-filtered biological products (sera, reagents, buffers, cell culture media and other liquid solutions), primarily for veterinary pharmaceutical and organ transplant applications. Biologos was founded in 1976 and is based in Montgomery, Illinois. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-04 |
Nektar - Commercial PEGylation Reagent Manufacturing Business
Huntsville, Alabama, United States Nektar's Commercial PEGylation Reagent Manufacturing Business site is a 124,000-square-foot, commercial-scale specialized manufacturing facility. Nektar's Commercial PEGylation Reagent Manufacturing Business is based in Huntsville, Alabama. |
Buy | $90M |
